XBRU:FAGR (Netherlands)  
Fagron SA logo

Fagron SA

€ 12.08 (-0.41%) Sep 29
P/E:
12.73
P/B:
2.37
Market Cap:
€ 880.50M ($ 859.77M)
Enterprise V:
€ 1.19B ($ 1.16B)
Volume:
111.15K
Avg Vol (2M):
102.75K
Also Trade In:
Volume:
111.15K
Market Cap €:
880.50M
Market Cap $:
859.77M
PE Ratio:
12.73
Avg Vol (2-Month):
102.75K
Enterprise Value €:
1.19B
Enterprise Value $:
1.16B
PB Ratio:
2.37
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Fagron SA is a pharmaceutical compounding company operating in Belgium. It acts as a supplier of pharmaceutical care to hospitals, pharmacies, clinics, and patients across the world. The company also produces pharmaceutical raw materials, equipment, and supplies which are needed to prepare medication in the pharmacy. Its segments are namely Fagron Europe, Fagron North America, Fagron South America and HL Technology.

Financials

XBRU:FAGR's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 625.786
EPS (TTM) (€) 0.95
Beta 0.44
Volatility % 29.14
14-Day RSI 31.53
14-Day ATR (€) 0.350912
20-Day SMA (€) 12.9055
12-1 Month Momentum % -24.13
52-Week Range (€) 11.54 - 18.73
Shares Outstanding (Mil) 72.89

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Fagron SA Filings

Document Form Filing Date
No Filing Data

Fagron SA Analysis

Share your research